Haverford Trust Co Has $505,000 Position in Globe Life Inc. (NYSE:GL)

Haverford Trust Co decreased its holdings in shares of Globe Life Inc. (NYSE:GL) by 8.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,770 shares of the company’s stock after selling 437 shares during the period. Haverford Trust Co’s holdings in Globe Life were worth $505,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in GL. Riverview Trust Co bought a new stake in shares of Globe Life during the third quarter worth about $32,000. Benjamin F. Edwards & Company Inc. increased its holdings in Globe Life by 88.4% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 599 shares of the company’s stock worth $50,000 after purchasing an additional 281 shares in the last quarter. LRI Investments LLC bought a new position in shares of Globe Life in the first quarter valued at approximately $72,000. Family Firm Inc. bought a new position in shares of Globe Life in the second quarter valued at approximately $54,000. Finally, Intact Investment Management Inc. purchased a new position in shares of Globe Life during the third quarter valued at approximately $73,000. 81.61% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on GL shares. Wells Fargo & Company raised their price objective on Globe Life from $108.00 to $117.00 and gave the company an “overweight” rating in a research note on Thursday, October 10th. Truist Financial raised their price target on shares of Globe Life from $90.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, October 25th. TD Cowen initiated coverage on shares of Globe Life in a research report on Wednesday, October 9th. They issued a “buy” rating and a $150.00 price objective for the company. Keefe, Bruyette & Woods lifted their target price on shares of Globe Life from $120.00 to $125.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 29th. Finally, Raymond James boosted their target price on Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a research note on Tuesday, October 15th. Five research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Globe Life has an average rating of “Moderate Buy” and an average target price of $124.50.

Globe Life Price Performance

Shares of NYSE GL opened at $108.97 on Friday. The company has a current ratio of 0.05, a quick ratio of 0.05 and a debt-to-equity ratio of 0.50. The stock has a fifty day simple moving average of $106.83 and a two-hundred day simple moving average of $94.36. Globe Life Inc. has a 1-year low of $38.95 and a 1-year high of $132.00. The firm has a market cap of $9.15 billion, a price-to-earnings ratio of 9.22 and a beta of 0.81.

Globe Life (NYSE:GL) last posted its quarterly earnings results on Wednesday, October 23rd. The company reported $3.49 earnings per share for the quarter, topping the consensus estimate of $3.06 by $0.43. Globe Life had a return on equity of 22.91% and a net margin of 19.04%. The company had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.46 billion. During the same quarter in the prior year, the company earned $2.71 EPS. The firm’s quarterly revenue was up 5.1% compared to the same quarter last year. Analysts anticipate that Globe Life Inc. will post 12.32 earnings per share for the current year.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.